Topic: Chutes and Ladders
Magenta Therapeutics recruits Pfizer exec John Davis, M.D., as CMO; Teva veteran Siggi Olafsson re-emerges at Hikma Pharmaceuticals; and more.
Axovant CEO Hung resigned, Arcturus CSO and COO Chivukula stepped down, Celgene spinoff emerged with Bob Hariri at the reins.
Arcturus is losing its second executive in as many weeks: CSO/COO Pad Chivukula, who will take an advisory role.
Longtime Catalent CFO joins Allergan, Arcturus board and ousted CEO exchange fire, Lilly diabetes executive jumps to MannKind.
Bob Hugin retires from Celgene, Voyager founder steps down as CEO, Boehringer named new U.S. chief to replace retiring Fonteyne.
NICE leader joined ABPI; Heptares co-founder will lead Merck’s new London center; Sanofi named a business transformation head.
Marshall has served as Sosei CSO since it bought Heptares but is now departing to take on a senior role at another business.
Pandion emerged with former Pfizer and Biogen execs; Hikma tapped ex-Fresenius scientist as CSO; Ipsen hired ex-Amgen oncology exec.
Novartis poached Pfizer oncology head Liz Barrett, Ed Kaye became Stoke Therapeutics' CEO, and Perrigo hired Uwe Röhrhoff as CEO.
Biogen executive Kress jumped to Syntimmune, Mendlein will guide Moderna's strategy and former FDA CIO Perakslis joined Roivant's Datavant.